179 related articles for article (PubMed ID: 17709794)
1. Buccal micronucleus cytome biomarkers may be associated with Alzheimer's disease.
Thomas P; Hecker J; Faunt J; Fenech M
Mutagenesis; 2007 Nov; 22(6):371-9. PubMed ID: 17709794
[TBL] [Abstract][Full Text] [Related]
2. Telomere length in white blood cells, buccal cells and brain tissue and its variation with ageing and Alzheimer's disease.
Thomas P; O' Callaghan NJ; Fenech M
Mech Ageing Dev; 2008 Apr; 129(4):183-90. PubMed ID: 18242664
[TBL] [Abstract][Full Text] [Related]
3. The buccal cytome and micronucleus frequency is substantially altered in Down's syndrome and normal ageing compared to young healthy controls.
Thomas P; Harvey S; Gruner T; Fenech M
Mutat Res; 2008 Feb; 638(1-2):37-47. PubMed ID: 17920640
[TBL] [Abstract][Full Text] [Related]
4. Association of micronucleus frequency with neurodegenerative diseases.
Migliore L; Coppedè F; Fenech M; Thomas P
Mutagenesis; 2011 Jan; 26(1):85-92. PubMed ID: 21164187
[TBL] [Abstract][Full Text] [Related]
5. Automation of the buccal micronucleus cytome assay using laser scanning cytometry.
Leifert WR; François M; Thomas P; Luther E; Holden E; Fenech M
Methods Cell Biol; 2011; 102():321-39. PubMed ID: 21704845
[TBL] [Abstract][Full Text] [Related]
6. Brief report: a novel application of buccal micronucleus cytome assay in systemic lupus erythematosus: a case-control study.
Al-Rawi ZS; Gorial FI; Tawfiq RF; Mohammed AK; Al-Naaimi AS; Al'aadhmi MA; Hayyawi AA
Arthritis Rheumatol; 2014 Oct; 66(10):2837-41. PubMed ID: 24981057
[TBL] [Abstract][Full Text] [Related]
7. A novel application of the buccal micronucleus cytome assay in oral lichen planus: a pilot study.
Sanchez-Siles M; Ros-Llor I; Camacho-Alonso F; Lopez-Jornet P
Arch Oral Biol; 2011 Oct; 56(10):1148-53. PubMed ID: 21429474
[TBL] [Abstract][Full Text] [Related]
8. Altered cytological parameters in buccal cells from individuals with mild cognitive impairment and Alzheimer's disease.
François M; Leifert W; Hecker J; Faunt J; Martins R; Thomas P; Fenech M
Cytometry A; 2014 Aug; 85(8):698-708. PubMed ID: 24616437
[TBL] [Abstract][Full Text] [Related]
9. Chromosome 17 and 21 aneuploidy in buccal cells is increased with ageing and in Alzheimer's disease.
Thomas P; Fenech M
Mutagenesis; 2008 Jan; 23(1):57-65. PubMed ID: 18048581
[TBL] [Abstract][Full Text] [Related]
10. Chromosomal DNA damage measured using the cytokinesis-block micronucleus cytome assay is significantly associated with cognitive impairment in South Australians.
Lee SL; Thomas P; Hecker J; Faunt J; Fenech M
Environ Mol Mutagen; 2015 Jan; 56(1):32-40. PubMed ID: 25099033
[TBL] [Abstract][Full Text] [Related]
11. Antecedent biomarkers of Alzheimer's disease: the adult children study.
Coats M; Morris JC
J Geriatr Psychiatry Neurol; 2005 Dec; 18(4):242-4. PubMed ID: 16306247
[TBL] [Abstract][Full Text] [Related]
12. Prediction of Alzheimer's disease using a cerebrospinal fluid pattern of C-terminally truncated beta-amyloid peptides.
Höglund K; Hansson O; Buchhave P; Zetterberg H; Lewczuk P; Londos E; Blennow K; Minthon L; Wiltfang J
Neurodegener Dis; 2008; 5(5):268-76. PubMed ID: 18309230
[TBL] [Abstract][Full Text] [Related]
13. Grape seed polyphenols and curcumin reduce genomic instability events in a transgenic mouse model for Alzheimer's disease.
Thomas P; Wang YJ; Zhong JH; Kosaraju S; O'Callaghan NJ; Zhou XF; Fenech M
Mutat Res; 2009 Feb; 661(1-2):25-34. PubMed ID: 19027755
[TBL] [Abstract][Full Text] [Related]
14. Extracellular amyloid beta 42 causes necrosis, inhibition of nuclear division, and mitotic disruption under both folate deficient and folate replete conditions as measured by the cytokinesis-block micronucleus cytome assay.
Lee SL; Thomas P; Fenech M
Environ Mol Mutagen; 2014 Jan; 55(1):1-14. PubMed ID: 24038346
[TBL] [Abstract][Full Text] [Related]
15. Buccal micronucleus cytome biomarkers in Algerian couples with idiopathic infertility.
Laanani I; Boutelis S; Bennoune O; Belaaloui G
Mutat Res Genet Toxicol Environ Mutagen; 2018 Nov; 835():32-35. PubMed ID: 30249480
[TBL] [Abstract][Full Text] [Related]
16. Buccal micronucleus cytome assay: results of an intra- and inter-laboratory scoring comparison.
Bolognesi C; Roggieri P; Ropolo M; Thomas P; Hor M; Fenech M; Nersesyan A; Knasmueller S
Mutagenesis; 2015 Jul; 30(4):545-55. PubMed ID: 25795005
[TBL] [Abstract][Full Text] [Related]
17. High Content, Multi-Parameter Analyses in Buccal Cells to Identify Alzheimer's Disease.
François M; Fenech MF; Thomas P; Hor M; Rembach A; Martins RN; Rainey-Smith SR; Masters CL; Ames D; Rowe CC; Macaulay SL; Hill AF; Leifert WR; The Australian Imaging Biomarkers And Lifestyle Study Research Group
Curr Alzheimer Res; 2016; 13(7):787-99. PubMed ID: 26975368
[TBL] [Abstract][Full Text] [Related]
18. Methodology for discovery of Alzheimer's disease blood-based biomarkers.
Maes OC; Schipper HM; Chertkow HM; Wang E
J Gerontol A Biol Sci Med Sci; 2009 Jun; 64(6):636-45. PubMed ID: 19366883
[TBL] [Abstract][Full Text] [Related]
19. Biomarkers for Alzheimer's disease.
Ward M
Expert Rev Mol Diagn; 2007 Sep; 7(5):635-46. PubMed ID: 17892369
[TBL] [Abstract][Full Text] [Related]
20. Buccal micronucleus cytome assay.
Thomas P; Fenech M
Methods Mol Biol; 2011; 682():235-48. PubMed ID: 21057932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
